<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

OUR RESOURCES

FEATURED CONTENT

Cancer Research UK: Partnering to accelerate cancer research translation and commercialisation

Key findings: Cancer Research UK’s Commercial Partnerships team brings together academic and industry expertise to help develop promising cancer treatments for the benefit of patients. The organisation engages with industry through a range of initiat...

Read More

Investorview: Propelling life science innovation from pre-seed to patients

Denmark’s Novo Seeds was established in 2007 in order to identify promising scientific research in the Nordic region, build life sciences companies that deliver commercially-attractive opportunities to investors and pharma partners, and develop novel...

Read More

CASE STUDY

Addex prepares PD-LID programme for 2019 Phase 3 registration trial

Key findings: Switzerland-based Addex Therapeutics is preparing its lead ca...

Read More

World-first accreditation to out-of-this-world applications for Oxehealth’s vital signs technology

Key learnings: Oxford-based Oxehealth has secured medical device accreditat...

Read More

Gates Foundation funding for DelSiTech’s silica-based drug delivery technology

Key learnings: DelSiTech has been awarded significant grant funding from th...

Read More
View More

EXPERT INSIGHT

Flu vaccines: Assessing the patent and innovation landscape

With winter in full swing, no doubt many of us will have come down with flu...

Read More

SPC you later to drug-device combinations

On 25 October 2018 the Court of Justice of the European Union (CJEU) handed...

Read More

Transforming health and social care: industry perspectives on AI

At a roundtable event in London in September 2018, CMS assembled a selectio...

Read More
View More

INVESTORVIEW

Investorview: Propelling life science innovation from pre-seed to patients

Denmark’s Novo Seeds was established in 2007 in order to identify promising...

Read More

Investorview: Ingredients for growth in life sciences investment

Industrifonden is an evergreen venture capital fund with headquarters in St...

Read More

Investorview: Why people are key in life science investments

Since it was founded in 1996, European venture capital firm HealthCap has i...

Read More
View More

LSX REPORT

Have your say on life sciences investment trends

LSX, formerly Biotech and Money, is conducting the 3rd Investor Perception ...

Read More

Key challenges to scaling up early-stage investment in the life sciences

Access to venture capital and effective fundraising tactics are key to buil...

Read More

Brexit: finite uncertainty

One might think that planning for uncertainty is something that biotech fir...

Read More
View More

WHITE PAPER

Medius Deal Watch: September-October 2018

There was much speculation last year that the US tax cuts that favoured the...

Read More

Infographic: C-suite challenges in life sciences 2018

In early 2017, LSX, formerly Biotech and Money, published the inaugural Inv...

Read More

C-suite survey uncovers life sciences challenges

For more than three-quarters (78%) of C-level respondents in the life scien...

Read More
View More

VIDEO

Interview with Avacta Group's Alastair Smith

In this video, Donald Leggatt, Head of Investor Relations at London South E...

Read More

Interview with HemoGenyx's Vladislav Sandler

In this video, Donald Leggatt, Head of Investor Relations at London South E...

Read More

Interview with Inmedix’s Andrew J. Holman

Andrew J. Holman, Co-Founder and Chief Executive Officer at Inmedix, talks ...

Read More
View More

EVENT

The Future of Digital Health: Q&A with Capricorn Venture Partners’ Marc Lambrechts

As new technologies look to play an ever-increasing role in addressing heal...

Read More

Investing in Early-Stage Innovation: Q&A with Sanofi Ventures’ Laia Crespo

How are established investors working to foster innovation in today’s biote...

Read More

Medtech Investment: Q&A with Panakès Partners’ Alessio Beverina

On 5 February 2019, a panel of leading medtech investors will open the 5th ...

Read More
View More

WEBINAR

Advanced therapies: Gaining market access in a challenging European environment

Listen to the final session in Phacilitate and LSX's (formerly known as Bio...

Read More

Overcoming commercialisation challenges in advanced therapies

Learn more about the commercialisation of advanced therapies in the on-dema...

Read More

Why whistleblowing should be a boardroom issue in life sciences

On-demand webinar now available New EU-wide whistleblowing regulations have...

Read More
View More